These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23135529)

  • 41. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.
    Hlatky MA; Boothroyd D; Vittinghoff E; Sharp P; Whooley MA;
    JAMA; 2002 Feb; 287(5):591-7. PubMed ID: 11829697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute effects of transdermal estrogen on hemodynamic and vascular reactivity in elderly postmenopausal healthy women.
    Manhem K; Brandin L; Ghanoum B; Rosengren A; Gustafsson H
    J Hypertens; 2003 Feb; 21(2):387-94. PubMed ID: 12569270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relaxation training and opioid inhibition of blood pressure response to stress.
    McCubbin JA; Wilson JF; Bruehl S; Ibarra P; Carlson CR; Norton JA; Colclough GW
    J Consult Clin Psychol; 1996 Jun; 64(3):593-601. PubMed ID: 8698954
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.
    Wassertheil-Smoller S; Hendrix SL; Limacher M; Heiss G; Kooperberg C; Baird A; Kotchen T; Curb JD; Black H; Rossouw JE; Aragaki A; Safford M; Stein E; Laowattana S; Mysiw WJ;
    JAMA; 2003 May; 289(20):2673-84. PubMed ID: 12771114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of hormone replacement therapy on hemodynamic responses of postmenopausal women to passive heating.
    Dunbar SL; Kenney WL
    J Appl Physiol (1985); 2000 Jul; 89(1):97-103. PubMed ID: 10904040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular reactivity to mental stress is not affected by alpha2-adrenoreceptor activation or inhibition.
    Philippsen C; Hahn M; Schwabe L; Richter S; Drewe J; Schachinger H
    Psychopharmacology (Berl); 2007 Feb; 190(2):181-8. PubMed ID: 17111173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
    Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
    Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Negative affect, pain and sex: the role of endogenous opioids.
    Frew AK; Drummond PD
    Pain; 2007 Nov; 132 Suppl 1():S77-S85. PubMed ID: 17512663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autonomic and cardiovascular function in postmenopausal women: the effects of estrogen versus combination therapy.
    Farag NH; Nelesen RA; Parry BL; Loredo JS; Dimsdale JE; Mills PJ
    Am J Obstet Gynecol; 2002 May; 186(5):954-61. PubMed ID: 12015521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.
    Chlebowski RT; Hendrix SL; Langer RD; Stefanick ML; Gass M; Lane D; Rodabough RJ; Gilligan MA; Cyr MG; Thomson CA; Khandekar J; Petrovitch H; McTiernan A;
    JAMA; 2003 Jun; 289(24):3243-53. PubMed ID: 12824205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulse pressure and coronary atherosclerosis progression in postmenopausal women.
    Nair GV; Waters D; Rogers W; Kowalchuk GJ; Stuckey TD; Herrington DM
    Hypertension; 2005 Jan; 45(1):53-7. PubMed ID: 15545509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
    Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM
    Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.
    Herrington DM; Reboussin DM; Klein KP; Sharp PC; Shumaker SA; Snyder TE; Geisinger KR
    Control Clin Trials; 2000 Jun; 21(3):257-85. PubMed ID: 10822123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.
    Newhouse PA; Dumas J; Wilkins H; Coderre E; Sites CK; Naylor M; Benkelfat C; Young SN
    Menopause; 2010 Jul; 17(4):860-73. PubMed ID: 20616673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.